drugset / Trial / NCT01758471
Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
RandomizedParallel-groupOpen-labelBasic science
Summary
This study is aimed to investigate the effect of acarbose on intestinal microbiome and incretins, therefore to explore the new pathways or new targets to treat type 2 diabetes.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-12
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 100 mg | Oral |
| Subject | Acarbose | Unknown | 150 mg | Oral |
| Comparator | Glipizide | Small molecule | 5 mg | Oral |